Over 1650 Total Lots Up For Auction at Five Locations - NJ Cleansweep 05/07, NJ Cleansweep 05/08, CA 05/09, CO 05/12, PA 05/15

A Pill a Day to Keep Cancer Away?

by Brendon Nafziger, DOTmed News Associate Editor | September 23, 2009

In mice, Dr. Satchi-Fainaro's drugs were able to inhibit about half of all growth of drug-resistant tumors. In other, more drug-sensitive, tumors, "[We] basically eradicated the tumor or tumor metastasis, or got them back to dormant size -- about one millimeter," she says.

"I'm very realistic," she says. "If I can regress the massive angiogenesis, and get [tumors] to regress to dormant size, it's basically transforming cancer into a chronically manageable disease, like diabetes. As long as we have drugs that are non-toxic, we can keep the tumors at this size and live like that [taking the drugs]."

stats
DOTmed text ad

Your Trusted Source for Sony Medical Displays, Printers & More!

Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.

stats

Dr. Satchi-Fainaro thinks this "tumor dormancy model" will be most appropriate for populations like women with mutations to the BRCA1 or BRCA2 genes, who have such a high risk for deadly breast cancer they often have both their breasts removed in precautionary double mastectomies. "To those women," Dr. Satchi-Fainaro says, "this can be a much better physical prophylactic treatment."

Currently, Dr. Satchi-Fainaro is licensing this treatment to a pharmaceutical company (she won't say which), and is also trying to figure out why cancers seem to thrive in bones. "That's the six million dollar question," she says.


Back to HCB News